Emerald Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, and NB2222 for treatment and management of several eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and NB3111.

Related Companies

TickerCompanyChg %Mkt Cap
EMBISkye Bioscience0%22.5M

Skye Bioscience Company Questions & Answers

Q

How do I buy Skye Bioscience (EMBI) stock?

A

You can purchase shares of Skye Bioscience (OTC: EMBI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Skye Bioscience's (EMBI) main competitors?

A

There are no as such competitors for Skye Bioscience.

Q

What is the target price for Skye Bioscience?

A

There is no analysis for Skye Bioscience

Q

How much is Skye Bioscience (EMBI) stock ?

A

The stock price for Skye Bioscience (OTC: EMBI) is $0.09 last updated Fri Jan 15 2021 20:59:41 GMT+0000 (Coordinated Universal Time).

Q

When is the next Skye Bioscience (EMBI) dividend?

A

There are no upcoming dividends for Skye Bioscience.

Q

When is Skye Bioscience (OTC:EMBI) reporting earnings?

A

There are no earnings for Skye Bioscience

Q

When is the upcoming split for EMBI?

A

There is no upcoming split for Skye Bioscience.